Stay updated on Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page.

Latest updates to the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAmyloidosis is now listed as a topic and the Genetic and Rare Diseases Information Center is added as a resource. The site revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded a glossary display option; updated page metadata to Revision: v3.4.0 and added the Last Update Submitted that Met QC Criteria label, with capitalization tweaks for No FEAR Act Data.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations section updated: added numerous site locations across the United States, Australia, Canada, and several European regions, and removed several previously listed sites.SummaryDifference2%

Stay in the know with updates to Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dexamethasone Plus IXAZOMIB in AL Amyloidosis Clinical Trial page.